Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    November 2022
  1. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
    DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
    PubMed     Abstract available


    May 2022
  2. SIBULESKY L, Leca N, Limaye AP, Ramasamy B, et al
    Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys.
    Transplantation. 2022 May 27. pii: 00007890-990000000-00059.
    PubMed     Abstract available


    April 2022
  3. MARTINI S, Tandoi F, Romagnoli R, Rizzetto M, et al
    Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients.
    Transplantation. 2022 Apr 11. pii: 00007890-990000000-00024.
    PubMed     Abstract available


  4. BEKKI Y, Crismale JF, Myers B, Schiano TD, et al
    Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the US: An Analysis of the OPTN/UNOS Database.
    Transplantation. 2022 Apr 6. pii: 00007890-990000000-00025.
    PubMed     Abstract available


  5. GUPTA G, Devarakonda T, Sharma A, Miles M, et al
    Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
    Transplantation. 2022;106:e234-e235.
    PubMed    


    March 2022
  6. BITTERMANN T, Mahmud N, Weinberg EM, Reddy KR, et al
    Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95041.
    PubMed     Abstract available


  7. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    PubMed    


    February 2022
  8. COTTER TG, Charlton M
    The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
    Transplantation. 2022;106:e166.
    PubMed    


  9. BEKKI Y, Myers B
    Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
    Transplantation. 2022;106:e165.
    PubMed    


  10. LIN SH, Lin MT, Wang CC, Chen CL, et al
    Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Transplantation. 2022;106:e163-e164.
    PubMed    


  11. WALLER KMJ, De La Mata NL, Rosales BM, Hedley JA, et al
    Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
    Transplantation. 2022;106:348-357.
    PubMed     Abstract available


    July 2021
  12. RICHTER BI, Parent B, Lonze BE
    The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV Naive Patients.
    Transplantation. 2021 Jul 22. pii: 00007890-900000000-95189.
    PubMed    


    May 2021
  13. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
    Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
    Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
    PubMed     Abstract available


    February 2021
  14. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    PubMed     Abstract available


    December 2020
  15. ADENUGBA A, Hornung M, Weigand K, Peschel G, et al
    Ribavirin Improves NK Cell IFNgamma Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95432.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: